These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8963485)

  • 1. Clinical trials: relevance of correlation between treatment modalities.
    Cleophas TJ
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):670-5. PubMed ID: 8963485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials: relevance of correlation between treatment responses.
    Cleophas TJ
    Eur J Clin Pharmacol; 1996; 50(1-2):1-6. PubMed ID: 8739804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criticism of cardiovascular studies with negative results due to a negative correlation.
    Cleophas TJ
    Angiology; 1996 Feb; 47(2):139-47. PubMed ID: 8595009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crossover trials are only useful when there is a positive correlation between the response to different treatment modalities.
    Cleophas TJ
    Br J Clin Pharmacol; 1996 Mar; 41(3):235-9. PubMed ID: 8866924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative analysis for crossover studies that accounts for between-group disparities in drug response.
    Cleophas TJ
    Eur J Clin Chem Clin Biochem; 1997 Oct; 35(10):775-9. PubMed ID: 9368796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of rheumatoid arthritis clinical trial outcome measures: a simulation study.
    Anderson JJ; Bolognese JA; Felson DT
    Arthritis Rheum; 2003 Nov; 48(11):3031-8. PubMed ID: 14613263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Trials: Design Flaws Associated with Use of a Placebo.
    Cleophas TJ
    Am J Ther; 1996 Jul; 3(7):529-534. PubMed ID: 11862286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotherapy in controlled psychopharmacology trials. Does it matter if we ignore it?
    Koek RJ; Hejran RN; Mintz J
    Contemp Clin Trials; 2005 Jun; 26(3):338-48. PubMed ID: 15911468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paired versus two-sample design for a clinical trial of treatments with dichotomous outcome: power considerations.
    Wacholder S; Weinberg CR
    Biometrics; 1982 Sep; 38(3):801-12. PubMed ID: 7171700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements.
    de Carvalho M; Costa J; Swash M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Dec; 6(4):202-12. PubMed ID: 16319023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative analysis for crossover studies that accounts for between-group disparities in drug response.
    Cleophas TJ
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):504-8. PubMed ID: 9401831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of extensions of bivariate rank sum statistics to the crossover design to compare two treatments through four sequence groups.
    Kawaguchi A; Koch GG; Ramaswamy R
    Biometrics; 2009 Sep; 65(3):979-88. PubMed ID: 19173698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.